Key result
Novel 8-variable nomogram outperforms ARISCAT for predicting pulmonary complications after high-altitude one-lung ventilation.
Why the study?
A validated nomogram for predicting postoperative pulmonary complications in patients undergoing one-lung ventilation thoracic surgery at high altitude was needed.
Does a novel 8-variable high-altitude-specific nomogram improve the prediction of postoperative pulmonary complications compared to the ARISCAT score in adults undergoing one-lung ventilation thoracic surgery at high altitude?
Cohort (n=492)
No
Does a novel 8-variable high-altitude-specific nomogram improve the prediction of postoperative pulmonary complications compared to the ARISCAT score in adults undergoing one-lung ventilation thoracic surgery at high altitude?
This study provides the first validated clinical prediction nomogram tailored for postoperative pulmonary complications in high-altitude one-lung ventilation surgery, significantly outperforming the standard lowland-derived ARISCAT score.
Answers are grounded in this paper and cite their sources.
May aid PPC risk stratification in high-altitude thoracic surgery; extends ARISCAT but leaves open prospective validation.
Objectives We aimed to develop and validate a novel nomogram for predicting postoperative pulmonary complications (PPCs) in patients undergoing one‐lung ventilation (OLV) thoracic surgery at high altitude. Methods A retrospective cohort study was conducted at the Tibet Autonomous Region People's Hospital (Lhasa, China; altitude 3650 m). We enrolled 570 adult OLV cases under general anesthesia from January 2020 to July 2024; after excluding incomplete records, 492 patients were analyzed and split chronologically into a development set ( n = 369) and a test set ( n = 123). PPCs were defined as pneumonia, atelectasis, ARDS, respiratory failure, reintubation, or ventilator support for > 48 h within the first postoperative week. Predictors were selected via LASSO regression and entered into multivariable logistic regression. Results PPCs occurred in 42.9% (211/492) of patients; this relatively high incidence likely reflects both the physiological challenges of the high‐altitude setting and our modified inclusion of all radiographic atelectasis. PPCs were associated with longer hospital stays (median 16 vs. 11 days, p < 0.001). Among the 43 raw features, the following eight were finally incorporated into the logistic regression model: age, Tibetan ethnicity, body mass index, preoperative heart rate, comorbid pneumonia, ASA physical status, bronchial blocker use, and surgical duration. The nomogram achieved AUCs of 0.808 (95% CI: 0.764–0.853) and 0.732 (95% CI: 0.642–0.823) in development and test cohorts, respectively, outperforming the ARISCAT score (AUCs: 0.708 and 0.555; p < 0.01). The nomogram showed good calibration (Hosmer–Lemeshow p > 0.05) and provided net benefit across risk thresholds of 12%–92% in the development set and 18%–74% in the test set. Conclusions This PPCs prediction tool for high‐altitude OLV patients incorporates easily obtainable clinical variables and demonstrates strong discrimination and calibration. Further prospective external validation in independent populations is required before routine clinical implementation.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) conducted a cohort in Patients undergoing one-lung ventilation thoracic surgery at high altitude (3650 m) (n=492). High-altitude 8-variable nomogram (age, Tibetan ethnicity, BMI, preoperative heart rate, comorbid pneumonia, ASA physical status, bronchial blocker use, surgical duration) vs. ARISCAT score was evaluated on Postoperative pulmonary complications (composite of pneumonia, atelectasis, ARDS, respiratory failure, reintubation, or ventilator support for >48 h) within 7 days after one-lung ventilation (AUC 0.808 (development) and 0.732 (test) vs ARISCAT AUC 0.708 and 0.555, 95% CI 0.642-0.823, p=<0.01). An 8-variable nomogram predicted postoperative pulmonary complications after high-altitude one-lung ventilation with an AUC of 0.808 (development) and 0.732 (test), outperforming ARISCAT.
Synapse has enriched 10 related papers. Consider them for comparative context: